Fundraising Fox

uFraction8

4 known investors

uFraction8 develops microfluidics-based filtration systems for bioprocessing applications, enabling energy-efficient harvesting and processing of microbial cell cultures for biopharmaceutical manufacturers. The technology targets industrial-scale bio-manufacturing and is positioned to replace conventional filters and centrifuges in cell culture processing.

Advanced ManufacturingBiotechCleantechDeep TechFoodTechHardware

Founders & leadership

DM
Dr Monika TomeckaFounder / CEO
DB
Dr Brian MillerFounder

Investors · 4

Alwyn CapitalSt. Petersburg
Blue Horizon CorporationZurich
Deep Science VenturesLondon
Foresight GroupreportedLondon · $1.3M – $6.3M

In the news

Scottish Biotech Firm uFraction8 Raises £3.4 Million in Funding to Commercialize Technology | BioPharm Internationalbiopharminternational.com · Apr 2026uFraction8 Raises €4.1M to Optimise Filtration in Biomanufacturingtherecursive.com · Mar 2025uFraction8 Secures £3.4M to Optimise Cell and Biomass Production - vegconomist - the vegan business magazinevegconomist.com · Feb 2025Biotech firm uFraction8 raises funds for expansion – Daily Businessdailybusinessgroup.co.uk · Feb 2025uFraction8 Raises £3.4M in Fundingfinsmes.com · Feb 2025Investors help uFraction8 move to next level – Daily Businessdailybusinessgroup.co.uk · Jan 2022

Frequently asked questions

What does uFraction8 do?
uFraction8 develops microfluidics-based filtration systems for bioprocessing applications, enabling energy-efficient harvesting and processing of microbial cell cultures for biopharmaceutical manufacturers. The technology targets industrial-scale bio-manufacturing and is positioned to replace conventional filters and centrifuges in cell culture processing.
Who founded uFraction8?
uFraction8 was founded by Dr Monika Tomecka, Dr Brian Miller.
Who are uFraction8's investors?
uFraction8's investors include Alwyn Capital, Blue Horizon Corporation, Deep Science Ventures, Foresight Group.